Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 8
2004 10
2005 13
2006 12
2007 17
2008 13
2009 11
2010 18
2011 8
2012 6
2013 10
2014 12
2015 9
2016 5
2017 9
2018 7
2019 10
2020 16
2021 15
2022 12
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

204 results

Results by year

Filters applied: . Clear all
Page 1
PET/CT in Multiple Myeloma: Beyond FDG.
Matteucci F, Paganelli G, Martinelli G, Cerchione C. Matteucci F, et al. Among authors: paganelli g. Front Oncol. 2021 Jan 25;10:622501. doi: 10.3389/fonc.2020.622501. eCollection 2020. Front Oncol. 2021. PMID: 33569348 Free PMC article. Review.
Theragnostic in neuroendocrine tumors.
Marini I, Sansovini M, Bongiovanni A, Nicolini S, Grassi I, Ranallo N, Monti M, DI Iorio V, Germanò L, Caroli P, Sarnelli A, Paganelli G, Severi S. Marini I, et al. Among authors: paganelli g. Q J Nucl Med Mol Imaging. 2021 Dec;65(4):342-352. doi: 10.23736/S1824-4785.21.03426-9. Epub 2021 Dec 9. Q J Nucl Med Mol Imaging. 2021. PMID: 34881852
Yttrium-based therapy for neuroendocrine tumors.
Bodei L, Cremonesi M, Paganelli G. Bodei L, et al. Among authors: paganelli g. PET Clin. 2014 Jan;9(1):71-82. doi: 10.1016/j.cpet.2013.10.001. PET Clin. 2014. PMID: 25029936 Review.
Radioligand therapies in cancer: mapping the educational landscape in Europe.
Bugani V, Battistelli L, Sansovini M, Monti M, Paganelli G, Gich I, Flotats A, Erba PA, Blay JY, la Fougère C, Van Poppel H, Charalambous A, Herrmann K, Giordano A, Györke T, Deroose C, Matteucci F, Carrió I. Bugani V, et al. Among authors: paganelli g. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2692-2698. doi: 10.1007/s00259-023-06217-0. Epub 2023 Apr 14. Eur J Nucl Med Mol Imaging. 2023. PMID: 37058168 Free PMC article.
Targeted radioactive therapy for prostate cancer.
De Giorgi U, Conteduca V, Gurioli G, Matteucci F, Paganelli G. De Giorgi U, et al. Among authors: paganelli g. Lancet. 2021 Aug 7;398(10299):487-488. doi: 10.1016/S0140-6736(21)01336-2. Lancet. 2021. PMID: 34364517 No abstract available.
CAR-T cell therapy: a potential new strategy against prostate cancer.
Schepisi G, Cursano MC, Casadei C, Menna C, Altavilla A, Lolli C, Cerchione C, Paganelli G, Santini D, Tonini G, Martinelli G, De Giorgi U. Schepisi G, et al. Among authors: paganelli g. J Immunother Cancer. 2019 Oct 16;7(1):258. doi: 10.1186/s40425-019-0741-7. J Immunother Cancer. 2019. PMID: 31619289 Free PMC article. Review.
Yttrium-labelled peptides for therapy of NET.
Bodei L, Cremonesi M, Grana CM, Chinol M, Baio SM, Severi S, Paganelli G. Bodei L, et al. Among authors: paganelli g. Eur J Nucl Med Mol Imaging. 2012 Feb;39 Suppl 1:S93-102. doi: 10.1007/s00259-011-2002-y. Eur J Nucl Med Mol Imaging. 2012. PMID: 22388625 Review.
Peptide receptor radionuclide therapy for advanced neuroendocrine tumors.
Bodei L, Cremonesi M, Kidd M, Grana CM, Severi S, Modlin IM, Paganelli G. Bodei L, et al. Among authors: paganelli g. Thorac Surg Clin. 2014 Aug;24(3):333-49. doi: 10.1016/j.thorsurg.2014.04.005. Epub 2014 Jun 9. Thorac Surg Clin. 2014. PMID: 25065935 Review.
204 results